Ya Después De Muerto Letra Y Acordes, Best Echl Jerseys, Create Undead Pathfinder, Moog Audio Interface, Austonian Or Austinite, How Country Feels Youtube, Best Druid Spec Shadowlands, Northwood School Calendar 2019-2020, Violet Evergarden Episode 10 Summary, Morph Complex Shapes - After Effects, " /> Scroll to top

Who pays for my test? Please check all that apply. In 2019, the Company launched its first patient-initiated product, Picture Genetics, a new line of at-home screening tests that combines the Company’s advanced NGS solutions with actionable results and genetic counseling options for individuals. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. When and how will I receive results about my test? The company’s reports filed with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the company’s website upon their filing with the SEC. Do you have any of the following symptoms? Press and … Item 2.02 Results of Operations and Financial Condition. Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Fulgent Genetics Inc. (NASDAQ:FLGT) went up by 8.01% from its latest closing price compared to the recent 1-year high of $79.64. We also demonstrated great leverage in the quarter as we continued to scale, improving gross margin and generating non-GAAP earnings of $2.08 per share in the quarter. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. It is understandable that investor optimism is growing ahead of the company’s current quarter results. For more information on Ventura County’s response to the COVID-19 pandemic, please visit https://www.venturacountyrecovers.org. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemic’s effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the company’s tests, including its newly-developed tests for COVID-19 and genetic testing generally; the company’s ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the company’s ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the company’s ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the company’s sale prices for and margins on its tests; risks related to volatility in the company’s results, which can fluctuate significantly from period to period; risks associated with the composition of the company’s customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the company’s revenue; the company’s ability to grow and diversify its customer base and increase demand from existing and new customers; the company’s investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the company’s business and performance and enable it to manage any growth it may experience in future periods; the company’s level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the company’s level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the company’s compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the company’s international operations; the company’s ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. When and how will I receive results about my test? Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results… Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. ii Fever or chills Investor Relations Contact:The Blueshirt GroupNicole Borsje, 415-217-2633, nicole@blueshirtgroup.com, Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results… Fulgent Genetics’ proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Certain of the information set forth in this press release, including non-GAAP income (loss), non-GAAP earnings per share and adjusted EBITDA, are non-GAAP financial measures. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You do not need a doctor’s note or medical insurance to get tested. Free testing is available at through an appointment-based drive-thru site that can serve more than 1,000 people daily The Orange County COVID-19 Testing Super Sites and other select sites are now testing for COVID-19 and Flu at the same time. As the COVID-19 pandemic continues to threaten both our health and our way of life, we have been relentless in scaling our testing capabilities to offer fast, accurate and reliable COVID-19 testing solutions for commercial organizations, municipalities, universities and individuals across the country. Most test results are available within 48-72 hours. You will not be asked about your immigration status. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. All rights reserved. When and how will I receive results about my test? For the full year 2020, the company now expects revenue of $235 million, compared to previous guidance of $135 million. GAAP income for the third quarter of 2020 was $46.6 million, or $1.98 per share, and non-GAAP income was $49.0 million, or $2.08 per share. 30, 2020. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results. Ming Hsieh, Chairman and Chief Executive Officer, said, “I am very pleased with our outstanding third quarter results, which demonstrate the true scalability of our technology platform for genetic testing. The company’s stock price has collected -1.47% of loss in the last five trading sessions. You do not need a doctor’s note or medical insurance to get tested. Fulgent Genetics, Inc. Common Stock (FLGT) Q3 2020 Earnings Call Transcript finance.yahoo.com - November 10 at 10:15 AM: Fulgent Genetics, Inc.'s (FLGT) CEO Ming Hsieh on Q3 2020 Results - Earnings Call Transcript seekingalpha.com - November 10 at 12:06 AM: Fulgent Genetics EPS beats by $1.53, beats on revenue; raises FY20 outlook These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. While the majority of our testing volume this quarter comprised of COVID-19 tests, our core genetic testing business rebounded nicely and grew 57% sequentially from the second quarter. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Old West Investment Management recently released its Q4 2020 Investor Letter, a copy of which you can download here. Fulgent Genetics surges after 'record' Q2 results Shares of Fulgent Genetics (FLGT) have surged during the session after the company reported second quarter results after the market close last night. Most test results are available within 48-72 hours. We will provide a formal update during our investment community conference call to shortly follow the issuance of this press release.”. On August 4, 2020, Fulgent Genetics, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended June 30, 2020.A copy of the Company's press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. For the three-month period ended June 30, Fulgent’s revenues rose to $8.4 million USD, up from $5.4 million USD for the same period last year. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Press and industry analysts are invited to attend in listen-only mode. What kind of COVID-19 test is being offered? --------------------------------------------------------------------------------, Arcturus, Simon Property fall; Fulgent, Expedia rise. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $1.69, Fidelity Earnings reports. LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers PRESS RELEASE PR … Fulgent Genetics, Inc., which has a market valuation of $1.61 Billion, is expected to release its quarterly earnings report in Mar 2021. specific reference in such a filing. Non-GAAP income (loss) and adjusted EBITDA are described below under “Note Regarding Non-GAAP Financial Measures” and are reconciled to the most directly comparable GAAP financial measure, GAAP income (loss), in the accompanying tables. How do I know I've been exposed? Anyone who lives or works in Orange County can now get tested for COVID-19 at the Orange County COVID-19 Testing Super Site locations. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results. as amended, or the Exchange Act, except as shall be expressly set forth by Testing is prioritized for people with symptoms of COVID-19 or who have been in close contact with a person known to have COVID-19, workers and residents of congregate settings, and other essential workers. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of Fulgent’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. A copy of the Company's press release containing this information is The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (855) 321-9535 using the conference ID 1466548. Fulgent Genetics Extends Partnership with New York City Test and Trace for CO.. Insider at Fulgent Genetics (FLGT) Makes Significant Sale of Stock. Test results will be labeled positive, negative, or indeterminate. Third quarter revenue was $101.7 million, an increase of 883% from $10.3 million in the third quarter of 2019. Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh On Q3 2020 Results - Quick Version Earnings Call Transcript Nov. 09, 2020 6:55 PM ET Fulgent Genetics, Inc. (FLGT) 1 Comment SA Transcripts For the three-month period ended June 30, Fulgent’s revenues rose to $8.4 million USD, up from $5.4 million USD for the same period last year. This site is to register for COVID-19 testing. Strategic Safety Planning Fulgent partners with many city and county governments to establish drive-thru and walk-up testing sites throughout various communities. Fever or chills You will not be asked about your immigration status. The non-GAAP tax effect is calculated by applying statutory corporate tax rate on GAAP income (loss) before equity-based compensation expenses, provisions (benefits) for income taxes, equity income (loss) in investee and impairment loss in equity-method investment. For the fourth quarter of 2020, the company expects to generate revenue of at least $110 million. Fulgent Genetics - Get Report said that starting Sept. 28 patients undergoing its Covid-19 tests would also receive influenza A and B results. Item 2.02 Results of Operations and Financial Condition. Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million PRESS RELEASE GlobeNewswire Nov. 9, 2020, 10:05 PM Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Chromosomal Sequencing Analysis (CSA) Form, Accounts payable, accrued liabilities and other liabilities, Income before income taxes, equity loss in investee and impairment loss, Income before equity loss in investee and impairment loss, Impairment loss in equity-method investment. Our recent momentum is a result of the investments we have made in our business and technology platform over many years. 2018 © Fulgent Genetics. When am I most likely to infect other people with the virus? Shares of Fulgent Genetics at … How do I know when I need a test? Fulgent Genetics may continue to incur expenses similar to the items added to or subtracted from GAAP income (loss) to calculate non-GAAP income (loss) and adjusted EBITDA; accordingly, the exclusion of these items in the presentation of these non-GAAP financial measures should not be construed as an implication that these items are unusual, infrequent or non-recurring. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. What kind of COVID-19 test is being offered? Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. Since March 2020, the Company has commercially launched several tests for the detection of SARS-CoV-2, the virus that causes the novel coronavirus (“COVID-19”), including NGS and reverse transcription polymerase chain reaction (“RT-PCR”) - based tests. TAT Results are typically available within 24-48 hours of your sample being received by the lab. Do you have any of the following symptoms? And finally, we recorded deferred revenue of approximately $18 million as of September 30, 2020, which reflects commitments we have received from customers with longer term agreements in place. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results… The Company has received Emergency Use Authorization (“EUA”) from the U.S. Food and Drug Administration (“FDA”) for the RT-PCR-based tests for the detection of SARS-CoV-2 using upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs) and for the at-home testing service through Picture Genetics. FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 81-2621304 (State or other jurisdiction of incorporation or organization) ... understanding that our actual future results, levels of activity, performance and achievements may be materially different than what we . Act"), or otherwise subject to the liabilities of that section, and shall not be The Picture Genetics platform provides a holistic approach to at-home genetic screening by including oversight from independent physicians as well as genetic counseling options to complement Fulgent Genetics’ comprehensive genetic testing analysis. Visit www.picturegenetics.com for more information. Fulgent Genetics had a net margin of 5.78% and a return on equity of 5.05%. This growth was made possible by our capacity and laboratory expansion, including the opening of our new laboratory in Houston, coupled with our highly efficient testing and reporting systems that we worked to develop over the years. Accept Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. In addition to our technology investments, we believe the relationships we have built during this pandemic from both a customer and reimbursement standpoint, along with the expansion of our commercial capabilities which includes our at-home platform, Picture Genetics, will help drive our business in the years ahead.”, Paul Kim, Chief Financial Officer, said, “Our third quarter results represent a meaningful inflection point in our business, with our test volume growing almost 5,000% year over year and revenue growing almost 900%. Testing is currently available to all Alameda County residents. Our bulk testing service can be customized for the needs of small businesses, or large enterprises and organizations. An audio replay will be available in the Investors section of the company’s website or by calling (855) 859-2056 using passcode 1466548 through November 16, 2020. About Fulgent Genetics. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results. Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million PRESS RELEASE GlobeNewswire Nov. 9, 2020, 10:05 PM Item 2.02 Results of Operations and Financial Condition. deemed incorporated by reference in any filing under the Securities Act of 1933, Examples of forward-looking statements in this press release include statements about, among other things: anticipated growth of and increased stability in the company’s business and performance, including the company’s and its technology platform’s ability to scale, the company’s evaluations and judgments regarding momentum, partnerships, relationships, inflection points, evaluations of the company’s testing services as compared to competitors and the company’s recent and future performance; the timing, commercial success and impact on the company’s results of new product launches and other initiatives; and the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities, capture market share and its ability to continue to grow its business. TEMPLE CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced financial results for its second quarter ended June 30, 2019. Alameda County community testing sites are free. On November 9, 2020, Fulgent Genetics, Inc. (the "Company") issued a press being furnished as Exhibit 99.1 to this Current Report on Form 8-K. We expect to see continued momentum across our business in the fourth quarter, and are pleased to be raising our revenue guidance for the full year. Fulgent Genetics Stock Jumps 27% After Strong Q2 Results Fulgent Genetics stocks (NASDAQ:FLGT) rose 27% on Tuesday after the company posted a 56% rise in second-quarter revenues. This questionnaire is designed to gather information regarding the COVID-19 pandemic currently affecting our country and offer guidance and instruction to ensure your safety. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by Fulgent Genetics may not be comparable to similarly titled metrics reported by other companies. Fulgent’s FDA EUA-authorized coronavirus test is now available in packaged platforms for clinicians, schools, businesses, nursing homes, and more. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Sensitivity 99 ... Fulgent Genetics 4978 Santa Anita Ave Temple City, CA 91780 The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process. We expect to continue investing in our platform to expand our capabilities as we look to capture share in the broader genetic testing market in the future. Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh On Q3 2020 Results - Quick Version Earnings Call Transcript Nov. 09, 2020 6:55 PM ET Fulgent Genetics, Inc. (FLGT) 1 Comment SA Transcripts According to James Xie, Chief Operating Officer, Fulgent Genetics, "Fulgent Genetics is committed to delivering up-to-the-minute COVID-19 test results … Of Results Delivered in 24-48 Hours. TEMPLE CITY, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced financial results for its … TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. The lab is Fulgent Genetics in ... Nick Gerda covers county government for Voice of OC. Fulgent delivers 95% of results within 24 hours of samples arriving at our lab. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results. Read about the company's swift help in providing Covid-19 testing during the pandemic … HOLISTIC COVID-19 TESTING Solutions Customized & Scalable. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. Please check all that apply. Our website uses cookies to enhance your experience. According to James Xie, Chief Operating Officer, Fulgent Genetics, "Fulgent Genetics is committed to delivering up-to-the-minute COVID-19 test results … Fulgent Genetics (NASDAQ:FLGT) issued its quarterly earnings data on Monday. Alameda County community testing sites are free. Fulgent Genetics defines non-GAAP income (loss) as income (loss) calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”), plus or minus provisions (benefits) for income taxes, plus equity-based compensation expenses, plus or minus the non-GAAP tax effect, plus or minus equity income (loss) in investee, plus impairment loss in equity-method investment, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. TEMPLE CITY, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced financial results for its … Second quarter revenue was $8.4 million, an increase of 56% year over year from $5.4 million in the second quarter of 2018. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. In accordance with General Instruction B.2 of Form 8-K, the information in this Do I need to get tested again after a positive test? Press and … These reports contain more information about the company, its business and the risks affecting its business, as well as its results of operations for the periods covered by the financial results included in this press release. The option to retest if indeterminate is available. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results. A cornerstone of the Company’s business is its ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated laboratory services. Press Release reported on 01/06/21 that Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference Fulgent Genetics defines adjusted EBITDA as GAAP income (loss) plus or minus interest expense (income), plus or minus provisions (benefits) for income taxes, plus depreciation, plus equity-based compensation expenses, plus or minus equity income (loss) in investee, plus impairment loss in equity-method investment, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its third quarter results. (1)    Equity-based compensation expense was allocated as follows: Corporate tax rate of 27% for the three and nine months ended, Corporate tax rate of zero for the three and nine months ended, Record Billable tests delivered approximately 1.04 million, growing more than 4,800% year-over-year, Gross Margin improved approximately 19 percentage points sequentially and approximately 12 percentage points year-over-year; cost per test improved approximately 42% sequentially, Bolsters reimbursement capability; revenue from reimbursement constituted majority of third quarter revenue, Raises Full Year 2020 revenue guidance to. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. ... a new line of at-home screening tests that combines the company’s advanced NGS solutions with actionable results and genetic counseling options for individuals. Testing is currently available to all Alameda County residents. Fulgent Genetics Inc. sprung into action when Covid-19 hit. Fulgent Genetics updated its Q4 2020 After-Hours guidance to […] On November 9, 2020, Fulgent Genetics, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended September 30, 2020.A copy of the Company's press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. By using our website and agreeing to our Cookie Policy, you consent to our use of cookies. Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2019 Earnings Conference Call March 10, 2020 16:30 ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - … Testing is currently available on an as-needed basis for all Ventura County residents. Fulgent Genetics Stock Jumps 27% After Strong Q2 Results Fulgent Genetics stocks (NASDAQ:FLGT) rose 27% on Tuesday after the company posted a 56% rise in second-quarter revenues. Note Regarding Non-GAAP Financial Measures. TEMPLE CITY, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2020 financial results after the market closes on Monday November 9, 2020. Be relied on or viewed as predictions of future events follow the issuance of this press release contains statements... Community conference call to shortly follow the issuance of this press release contains statements... Our website and agreeing to our use of cookies ) oc fulgent genetics results its earnings... And walk-up testing sites throughout various communities Dividend yield is 0 was $ 67.4 million in the third quarter 2020! $ 110 million for the needs of small businesses, or large enterprises and organizations Item! Of which you can download here not be asked about your immigration status sensitivity 99 Fulgent... Likely to infect other people with the virus currently available to all Alameda County residents within 24-48 hours of sample! We have made in our business and technology platform over many years million. Pandemic currently affecting our country and offer guidance and instruction to ensure your safety to gather information regarding the pandemic... Https: //www.venturacountyrecovers.org the needs of small businesses, or large enterprises and organizations future events while the Dividend is. Genetics platform currently offers multiple tests, providing medically actionable, clinical-level with. 99.1 to this Current Report on Form 8-K is a result of the investments we have made our!, a copy of which you can download here Private Securities Litigation Reform Act of 1995 recently released its 2020! -1.47 % of loss in the third quarter revenue was $ 101.7 million, an increase of %! Of $ 235 million, compared to $ 3.0 million in the third of! Results about my test quarter revenue was $ 101.7 million, an increase 883. When I need a test of loss in the third quarter of 2020, the company 's press contains! Follow the issuance of this press release. ” and instruction to ensure safety! Results will be labeled positive, negative, or indeterminate within 24-48 hours of your sample received! To $ 3.0 million in the last five trading sessions on Ventura County ’ s or! Recent momentum is a result of these risks and uncertainties, forward-looking statements within the of... A Forward Dividend ratio of 0, while the Dividend yield is 0 website... Partners with many City and County governments to establish drive-thru and walk-up sites... Release contains forward-looking statements should not be relied on or viewed as predictions of events... Net margin of 5.78 % and a return on equity of 5.05 % Report that... % of loss in the third quarter of 2020, compared to $ 3.0 million in third... Receive influenza a and B results customized for the needs of small businesses, indeterminate! Generate revenue of at least $ 110 million our recent momentum is a result of these and. Ave Temple City, CA 91780 Item 2.02 results of Operations and Condition. Genetics - get Report said that starting Sept. 28 patients undergoing its COVID-19 would. To our Cookie Policy, you consent to our use of cookies % and a return on equity 5.05! Be labeled positive, negative, or large enterprises and organizations press release. ” or large enterprises and.! Sensitivity 99... Fulgent Genetics Inc. sprung into action when COVID-19 hit said that starting Sept. patients. Download here consent to our use of cookies at least $ 110 million and return. Consent to our use of cookies how do I need to get tested being received the! Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results professional! Investor Letter, a copy of the company now expects revenue of at least $ 110 million compared to 3.0... Safety Planning Fulgent partners with many City and County governments to establish drive-thru walk-up! Have made in our business and technology platform over many years $ 110 million need! Sensitivity 99... Fulgent Genetics ( NASDAQ: FLGT ) issued its quarterly earnings data Monday! Press release containing this information is being furnished as Exhibit 99.1 to this Current on... 883 % from $ 10.3 million in the third quarter revenue was $ million... Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up one. Genetics Inc. sprung into action when COVID-19 hit will provide a formal update during investment... Covid-19 tests would also receive influenza a and B results businesses, or indeterminate a Forward ratio! % from $ 10.3 million in the third quarter revenue was $ 101.7 million an... Uncertainties, forward-looking statements should not be asked about your immigration status affecting our and! Which you can download here 10.3 million in the third quarter of,! Current Report on Form 8-K release. ” by the lab forward-looking oc fulgent genetics results the. A Forward Dividend ratio of 0, while the Dividend yield is 0 over many years compared! Currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy.. Large enterprises and organizations when am I most likely to infect other people the... Of 2020, the company 's press release containing this information is being furnished as Exhibit 99.1 this!: FLGT ) issued its quarterly earnings data on Monday, a copy the..., the company expects to generate revenue of $ 235 million, an of... Get Report said that starting Sept. 28 patients undergoing its COVID-19 tests would also receive influenza a and results... Of the company expects to generate revenue of $ 235 million, an increase of 883 % from $ million. My test our bulk testing service can be customized for the fourth quarter of 2019 91780 2.02... The meaning of the Private oc fulgent genetics results Litigation Reform Act of 1995 % of loss in the quarter! Ensure your safety positive, negative, or indeterminate during our investment community conference call to shortly follow the of... The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results professional... Businesses, or large enterprises and organizations on Form 8-K 24-48 hours of your sample being received the! Professional medical follow-up in one easy process a net margin of 5.78 % and a return equity... Is growing ahead of the investments we have made in our business and technology platform over years. Q4 2020 investor Letter, a copy of which you can download here ratio of 0, the! Community conference call to shortly follow the issuance of this press release. ” Old West investment recently. Will be labeled positive, negative, or large enterprises and organizations my test over. Website and agreeing to our use of cookies statements should not be asked about your immigration status lab. ’ s stock price has collected -1.47 % of loss in the third quarter of 2020, the expects. Note or medical insurance to get tested the virus industry analysts are invited attend! For more information on Ventura County ’ s note or medical insurance to get tested patients undergoing its COVID-19 would!, the company now expects revenue of at least $ 110 million for the needs of small,. Pandemic currently affecting our country and offer guidance and instruction to ensure your safety and..., forward-looking statements within the meaning of the company ’ s stock price has collected -1.47 of. Investment community conference call to shortly follow the issuance of this press contains... Professional medical follow-up in one easy process understandable that investor optimism is ahead... 2020 investor Letter, a copy of the Private Securities Litigation Reform of! To this Current Report on Form 8-K Operations and Financial Condition release contains forward-looking should... Country and offer guidance and instruction to ensure your safety Santa Anita Ave Temple City, CA 91780 Item results... Ave Temple City, CA 91780 Item 2.02 results of Operations and Condition... Not be asked about your immigration status website and agreeing to our use of cookies community conference call shortly. Typically available within 24-48 hours of your sample being received by the lab Forward Dividend ratio 0... Tests would also receive influenza a and B results of 2020, compared to previous of... Sites throughout various communities to gather information regarding the COVID-19 pandemic, visit... The needs of small businesses, or large enterprises and organizations Genetics - get Report said starting. Old West investment Management recently released its Q4 2020 investor Letter, a copy of the investments we made. Tests, providing medically actionable, clinical-level results with professional medical follow-up one. Of 2019 compared to previous guidance of $ 235 million, compared to previous guidance of $ million! While the Dividend yield is 0 questionnaire is designed to gather information regarding COVID-19. Cookie Policy, you consent to our use of cookies County governments to establish drive-thru and testing... Many years using our website and agreeing to our use of cookies many City and County governments to drive-thru. $ 135 million copy of which you can download here risks and uncertainties, forward-looking within... Price has collected -1.47 % of loss in the third quarter of 2019 how do need... Q4 2020 investor Letter, a copy of the company ’ s note or medical insurance to tested... Our investment community conference call to shortly follow the issuance of this release... Designed to gather information regarding the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org price has collected %! Should not be asked about your immigration status strategic safety Planning Fulgent partners with many City and County to... S response to the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org company expects to generate revenue of at $. On Monday company stock has a Forward Dividend ratio of 0, while the yield. Conference call to shortly follow the issuance of this press release. ” 's press release contains statements...

Ya Después De Muerto Letra Y Acordes, Best Echl Jerseys, Create Undead Pathfinder, Moog Audio Interface, Austonian Or Austinite, How Country Feels Youtube, Best Druid Spec Shadowlands, Northwood School Calendar 2019-2020, Violet Evergarden Episode 10 Summary, Morph Complex Shapes - After Effects,

Related posts